FMI, a leading market research and analysis firm, forecasts a significant upswing in the Global Allergy Immunotherapy Industry. In 2023, the market is set to reach an estimated value of US$ 1.74 billion, with a remarkable compound annual growth rate (CAGR) of 8.9% projected from 2023 to 2033. By 2033, the market is...